Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Commonwealth Biotechnol. (NasdaqSC:CBTE)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Location
601 Biotech Drive
Richmond, VA 23235
Phone: (804) 648-3820
Fax: (804) 648-2641
Email: info@cbi-biotech.com
Employees (last reported count): 43
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 76%
·Institutional: 24% (101% of float)
(2 institutions)
·Net Inst. Selling: 362.0K shares (+253.13%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Commonwealth Biotechnologies, Inc. (CBI) provides research and development support services on a contract basis to the biotechnology industry. The Company's customers consist of private companies, academic institutions and government agencies, all of which use biological processes to develop products for healthcare, agricultural and other purposes. The Company's revenues are derived principally from providing macromolecular synthetic and analytical services to researchers in the biotechnology industry, or to researchers who are engaged in life sciences research in government or academic labs throughout the world. The Company's approach to providing services is called Concept-to-Clinic, which consists of design, development, implementation and testing. CBI provides the required services for a start-up company with research and development needs, or an established firm wishing to move a product through clinical regulation.
More from Market Guide: Expanded Business Description

Financial Summary
Commonwealth Biotechnologies provides sophisticated research and development support services on a contract basis to the biotechnology industry. For the six months ended 6/30/01, revenues rose 22% to $2.8 million. Net loss totalled $621 thousand vs. income of $9 thousand. Results reflect increased revenues from commercial contracts and initial revenue from clinical services and licensing fees, offset by increased compensation, marketing and depreciation expenditures.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Richard Freer, Ph.D., 58
Chairman
$208K--  
Robert Harris, Ph.D., 49
Pres
209K$281K
Thomas Reynolds, 38
Sr. VP, Sec.
147K128K
James Brennan, 48
Controller
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:CBTEAs of 31-Aug-2001
Price and Volume
52-Week Low
on 27-Apr-2001
$3.00 
Recent Price$4.28 
52-Week High
on 26-Sep-2000
$9.875
Beta0.29 
Daily Volume (3-month avg)909 
Daily Volume (10-day avg)1,000 
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-34.2%
52-Week Change
relative to S&P500
-11.7%
Share-Related Items
Market Capitalization$8.88M
Shares Outstanding2.08M
Float500.0K
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.27 
Earnings (ttm)-$0.81 
Earnings (mrq)-$0.07 
Sales (ttm)$2.53 
Cash (mrq)$0.23 
Valuation Ratios
Price/Book (mrq)1.89 
Price/EarningsN/A 
Price/Sales (ttm)1.69 
Income Statements
Sales (ttm)$4.89M
EBITDA (ttm)-$615.0K
Income available to common (ttm)-$1.55M
Profitability
Profit Margin (ttm)-31.7%
Operating Margin (ttm)-28.1%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-15.64%
Return on Equity (ttm)-31.21%
Financial Strength
Current Ratio (mrq)1.94 
Debt/Equity (mrq)0.90 
Total Cash (mrq)$483.0K
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
0 
Daily Volume1,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.